Drug Monitoring Research Institute (DMRI) is an independent CRO providing clinical research support to the pharmaceutical industry for various phases of drug development (IND, NDA and ANDA submissions).

Established in 1998, DMRI has no ownership linkage with any pharmaceutical company and offers total confidentiality, independence and no conflict of interest.

DMRI Offers:

• Bioequivalence / Bioavailability (BE / BA) Studies
• Phase II-IV
  
• Data Management and Biostatistics
  
• Medical Writing
  
• Regulatory Affairs

Our USPs are:

• All clinical services under one roof
  
• Comprehensive total quality management systems
• An established brand reputation in the industry
• Constantly upgrading technology and skills
• Standard processes specifically designed for high quality deliverables
• Skilled, qualified, talented, hardworking and dedicated staff
• Access to a huge volunteer database including female volunteers in the post-menopausal group
• Meeting critical timelines